27/10/2020 - 15:48

Proteomics’ $6m cap-raising lures UK institutions

27/10/2020 - 15:48

Bookmark

Save articles for future reference.

ASX-listed Proteomics International Laboratories has locked away $6m in cash via a heavily oversubscribed placement to UK and local institutions and other sophisticated investors to progress the marketing and development of its ‘PromarkerD’ predictive kidney disease test. Euroz-Hartleys Securities Ltd acted as sole lead manager for the placement to new and existing investors and Candour Advisory acted as Corporate Adviser.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options